L-Lactylation: A Novel Epigenetic Modification Shaping Disease Biology and ANT BIO PTE. LTD.'s Antibody Solutions

L-Lactylation: A Novel Epigenetic Modification Shaping Disease Biology and ANT BIO PTE. LTD.'s Antibody Solutions

 

1. Concept: Lysine Lactylation (Kla) and Its Isomers

Lysine lactylation (Kla) is an emerging post-translational modification (PTM) characterized by the covalent attachment of lactate-derived lactyl groups to lysine residues of proteins. Primarily triggered by intracellular lactate accumulation during metabolic reprogramming, lactylation predominantly modifies histones, altering their spatial conformation to regulate gene transcription and downstream cellular processes. Beyond histones, lactylation also impacts non-histone proteins, linking cellular metabolism to epigenetic regulation, signal transduction, and disease pathogenesis.

Three key lactylation isomers have been identified, each with distinct origins and biological roles:

  • L-Lactyllysine (Kla-L): The primary biologically relevant isomer, driven by L-lactate (the major lactate form in humans and eukaryotes) produced via glycolysis. It is a central mediator of the Warburg effect and is widely involved in physiological and pathological processes.
  • D-Lactyllysine (Kla-D): A stereoisomer formed non-enzymatically via the glyoxalase pathway. S-D-lactylglutathione (LGSH), generated by glyoxalase 1 (GLO1) from methylglyoxal (MGO) and glutathione, reacts with proteins to form Kla-D.
  • Carboxyethyllysine (Kce): Formed by the direct reaction of MGO (a glycolysis byproduct) with lysine residues, occurring at lower levels than MGO-derived arginine modifications.

2. Research Frontiers of L-Lactylation

Contemporary research on L-lactylation focuses on expanding its mechanistic understanding and translational potential. A key frontier is the identification of enzymes regulating lactylation (writers, erasers, readers) to unravel its reversible regulatory network. Another prominent direction involves mapping lactylation landscapes in diverse diseases, particularly cancer and autoimmune disorders, to identify disease-specific modification patterns.

. Additionally, research is exploring L-lactylation as a therapeutic target—for example, modulating lactylation to reverse metabolic reprogramming in tumor cells or suppress excessive inflammation in sepsis. Furthermore, the development of high-specificity detection tools is advancing the quantification and localization of lactylation in complex biological samples.

3. Research Significance of L-Lactylation

L-lactylation research holds profound implications for understanding metabolism-epigenetics crosstalk and disease mechanisms:

  • Metabolic-epigenetic link: L-lactylation bridges glycolytic metabolism and gene regulation, explaining how metabolic reprogramming drives disease progression (e.g., Warburg effect in cancer).
  • Disease biomarker potential: Aberrant L-lactylation correlates with disease severity in sepsis, cancer, and autoimmune disorders, offering non-invasive diagnostic opportunities.
  • Therapeutic target validation: Modulating L-lactylation enzymes or modification sites provides novel strategies for treating metabolism-related diseases.
  • Basic science insights: Studying L-lactylation advances understanding of PTM networks and their role in cellular homeostasis.
  • Translational value: Clinical validation of lactylation-targeted interventions paves the way for precision medicine approaches.

4. Relevant Mechanisms, Research Methods and Product Applications

4.1 Core Mechanisms of L-Lactylation in Disease

Cancer

Tumor cells exhibit the Warburg effect—aerobic glycolysis producing excessive L-lactate, which induces histone lactylation. This modification upregulates oncogene expression, promotes tumor cell proliferation, and suppresses cytotoxic T lymphocyte (CTL) activity, facilitating immune escape. Lactate also accumulates in the tumor microenvironment (TME), altering pH balance and supporting tumor growth.

Infection and Inflammation

In sepsis, macrophages uptake extracellular lactate, promoting HMGB1 lactylation via a p300/CBP-dependent mechanism. Lactylated HMGB1 is released in exosomes, causing endothelial barrier dysfunction and increased vascular permeability, exacerbating inflammation. Lactylation also regulates macrophage polarization and inflammatory gene expression.

Autoimmune Diseases

In ulcerative colitis, increased lactate uptake inhibits NLRP3 inflammasome activation and macrophage pyroptosis via H3K18 lactylation, ameliorating disease severity. In systemic lupus erythematosus, elevated lactate and lactylation levels modulate interferon production in macrophages.

4.2 Key Research Methods for L-Lactylation Detection

  • Immunoblotting (WB): Uses lactylation-specific antibodies to detect modified proteins in cell lysates or tissue homogenates.
  • Immunohistochemistry (IHC)/Immunofluorescence (IF): Visualizes lactylation localization in tissues or cells, particularly histone lactylation in the nucleus.
  • Mass Spectrometry (MS): Identifies lactylation sites and quantifies modification levels at the proteome scale.
  • Chromatin Immunoprecipitation (ChIP): Maps histone lactylation at specific genomic loci to study its role in gene transcription.
  • Functional assays: Evaluates the impact of lactylation on protein function, cell proliferation, and inflammatory responses.

4.3 Product Applications of ANT BIO PTE. LTD.

ANT BIO PTE. LTD. delivers high-specificity antibody solutions for L-lactylation research through its Starter sub-brand—specializing in PTM-targeted antibodies. All products are validated for sensitivity, specificity, and reproducibility, complying with EU 98/79/EC, ISO9001, and ISO13485 certifications. Key offerings:

  • L-Lactyl Lysine Rabbit Polyclonal Antibody (S0B0719): Recognizes L-lactylated lysine residues in histones and non-histone proteins, suitable for WB, IHC, and IF applications.
  • Histone H3 (Lactyl K9) Recombinant Rabbit mAb (S0B0756, S-R397): Specifically targets lactylated K9 on histone H3, enabling precise analysis of this key epigenetic mark in gene regulation.
  • Lactyl Histone H3 Antibody MiniAb Set (S0M1014): A comprehensive kit priced at $210, providing essential tools for studying histone H3 lactylation, ideal for basic research and drug discovery.

These antibodies support diverse research needs—from validating lactylation in disease models to mapping modification landscapes—empowering researchers to advance understanding of this novel PTM.

5. Brand Mission of ANT BIO PTE. LTD.

ANT BIO PTE. LTD. is dedicated to empowering global life science research and clinical practice through high-quality, innovative reagents and professional services. As a leading provider of life science solutions, the company offers a comprehensive portfolio including antibodies, recombinant proteins, ELISA kits, and general laboratory reagents, with three specialized sub-brands: Absin (general reagents and kits), Starter (antibodies), and UA (recombinant proteins). Leveraging advanced R&D platforms—including recombinant antibody development (rabbit/mouse monoclonal), protein expression systems (E.coli, CHO, HEK293, Insect Cells), One-Step ELISA, and PTM Pan-Modification Antibody platforms—ANT BIO PTE. LTD. adheres to the principles of "precision, reliability, and customer-centricity." The company strives to deliver cost-effective products and tailored support to researchers, clinicians, and biopharmaceutical partners, accelerating the translation of scientific discoveries into improved patient care and advancing global health.

6. Related Product List

Catalog Number

Product Name

Host

Conjugation

Original Price

Current Price

S0M1014

Lactyl Histone H3 Antibody MiniAb Set

N/A

N/A

$210

$210

S0B0756

Histone H3 (Lactyl K9) Recombinant Rabbit mAb (S-R397)

Rabbit

Unconjugated

Inquiry

Inquiry

S0B0719

L-Lactyl Lysine Rabbit Polyclonal Antibody

Rabbit

Unconjugated

Inquiry

Inquiry

7. AI Disclaimer

This article is AI-compiled and interpreted based on the original work. All intellectual property (e.g., images, data) of the original publication shall belong to the journal and the research team. For any infringement, please contact us promptly and we will take immediate action.

 

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.